How Much Did Dynalabs Raise?
Funding & Key Investors

Dynalabs has successfully secured a significant capital injection, marking a pivotal moment in its corporate trajectory. With a total funding accumulation of $1M, the organization is well-positioned to expand its specialized laboratory services. This recent strategic investment of $1M underscores the market confidence in the company's ability to provide critical analytical support within the pharmaceutical sector, ensuring that high-stakes testing remains a cornerstone of its operational model.

What is Dynalabs?

Dynalabs
Healthcare ServicesMedical Laboratories & Imaging Centers

Founded in 2003 and headquartered in Missouri, Dynalabs operates as a specialized provider of analytical laboratory testing services tailored for the pharmacy industry. The company maintains a robust market position by offering a comprehensive suite of services, including potency and purity assessments, sterility testing, endotoxin analysis, particulate matter evaluation, and long-term stability studies. By acting as a vital link in the pharmaceutical supply chain, Dynalabs ensures that compounding pharmacies and manufacturers adhere to stringent quality control standards, thereby mitigating risks associated with product efficacy and patient safety. Its long-standing presence in the industry has established it as a reliable partner for organizations requiring precise, regulatory-compliant data to support their manufacturing and distribution workflows.

How much funding has Dynalabs raised?

Dynalabs has raised a total of $1M across 1 funding round:

2020

Debt

$1M

Debt (2020): $1M with participation from PPP

Key Investors in Dynalabs

PPP

Public-Private Partnership

What's next for Dynalabs?

The infusion of capital is expected to catalyze the next phase of growth for Dynalabs, particularly as the demand for rigorous pharmaceutical quality assurance continues to rise. With this major strategic investment, the company is likely to focus on scaling its laboratory infrastructure, potentially integrating advanced automation technologies to increase throughput and precision. Furthermore, the funding provides the necessary liquidity to enhance its service portfolio, allowing the firm to address emerging regulatory requirements and expand its footprint in the broader healthcare infrastructure market. As Dynalabs moves forward, the focus will remain on maintaining its reputation for technical excellence while leveraging its strengthened balance sheet to capture a larger share of the analytical testing market, ultimately reinforcing its role as an essential service provider in the pharmaceutical ecosystem.

See full Dynalabs company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Healthcare Services industry

Elderly Care ServicesHealthcare Services
Healthcare ServicesMental Health & Rehabilitation Facilities
Elderly Care ServicesHealthcare Services
Healthcare ServicesVeterinary Services

Frequently Asked Questions Regarding Dynalabs Financial Insights

What are the most recent funding rounds that Dynalabs has completed, and what were the funding rounds?
Dynalabs has recently completed 1 funding rounds: Debt on Apr 5, 2020.
What is the total amount of funding Dynalabs has raised to date?
Dynalabs has raised a total of $1M in funding to date.
How many funding rounds has Dynalabs completed?
Dynalabs has completed 1 funding rounds.
How much funding did Dynalabs raise in its most recent funding round?
Dynalabs raised $1M in its most recent funding round.
Who are the lead investors in Dynalabs's latest funding round?
The lead investor in Dynalabs's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Dynalabs's history?
The largest funding round in Dynalabs's history was $1M.
See more information about Dynalabs